Hyderabad-based pharmaceutical company Biological E has received WHO approval to be an additional manufacturing site for the Janssen/Johnson & Johnson Covid-19 vaccine.
Congratulating the pharma company over the same, the US embassy in India tweeted, “Congratulations to @biological_e on its @WHO approval as an additional manufacturing site for the Janssen/Johnson & Johnson COVID-19 vaccine!”
“Great progress for the Quad Vaccine and #USIndiaHealth partnerships through US technical support and @DFCgov financing,” the tweet further said.
Congratulations to @biological_e on its @WHO approval as an additional manufacturing site for the Janssen/Johnson & Johnson COVID-19 vaccine! Great progress for the Quad Vaccine and #USIndiaHealth partnerships through U.S. technical support and @DFCgov financing. pic.twitter.com/u35eU9YhZZ— U.S. Embassy India (@USAndIndia) June 22, 2022
Biological E, the manufacturer of Corbevax vaccine, has an alliance with Johnson & Johnson on the Janssen Covid-19 vaccine.
The national drugs controller had in April this year cleared children as young as 5 years old to be vaccinated with Biological E’s Corbevax.
While Hyderabad-based Biological E is manufacturer of Corbevax, the beginnings of the vaccine can be traced to the National School of Tropical Medicine at the Baylor College of Medicine (BCM) in Houston, Texas. The school had been working on recombinant protein vaccines for coronaviruses SARS and MERS for a decade.
Read all the Latest News , Breaking News , watch Top Videos and Live TV here.
Comments
0 comment